Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues-Reference-Cited by-同舟云学术

Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues

Published:2019-04-25 Issue:5 Volume:14 Page:1020-1029
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Graves Paul R.¹,Aponte-Collazo Lucas J.²,Fennell Emily M. J.²,Graves Adam C.²,Hale Andrew E.³,Dicheva Nedyalka²,Herring Laura E.²^ORCID,Gilbert Thomas S. K.²^ORCID,East Michael P.²,McDonald Ian M.²,Lockett Matthew R.⁴^ORCID,Ashamalla Hani¹,Moorman Nathaniel J.³,Karanewsky Donald S.⁵,Iwanowicz Edwin J.⁵,Holmuhamedov Ekhson⁶,Graves Lee M.²^ORCID

Affiliation:

1. Department of Radiation Oncology, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York 11215, United States

2. Department of Pharmacology and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Microbiology and Immunology and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Department of Chemistry and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

5. Madera Therapeutics LLC, Chapel Hill, North Carolina 27517, United States

6. Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142292, Russian Federation

Funder

National Cancer Institute

Russian Science Foundation

New York-Presbyterian Brooklyn Methodist Hospital

University Cancer Research Fund

Publisher

American Chemical Society (ACS)

Link

http://pubs.acs.org/doi/pdf/10.1021/acschembio.9b00222

Reference41 articles.